V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10368858 | 10056595 | 1.85 | 55.6 | null | null | 2019-05-11 | Cisplatin + Radiotherapy | 02 | null | ACALABRUTINIB | 101322649 |
| 10369028 | 10056596 | 1.75 | 147.5 | null | 2017-11-29 | 2017-11-29 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100358720 |
| 10369039 | 10056597 | 1.59 | null | Adjuvant (A) | 2018-10-14 | 2018-10-14 | BORTEZOMIB + THALIDOMIDE | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101055997 |
| 10369060 | 10056598 | 1.85 | 77.05 | null | 2020-06-19 | 2020-06-26 | Bortezomib + Cyclophos + Dex | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101710990 |
| 10369153 | 10056599 | 1.65 | 67.15 | null | 2018-04-11 | 2018-04-19 | null | 02 | null | CISPLATIN + VINORELBINE | 100332133 |
| 10369157 | 10056600 | 1.66 | 59.4 | Not known (9) | 2019-08-15 | 2019-08-15 | CHLORAMBUCIL + OBINUTUZUMAB | null | N | CHLORAMBUCIL + OBINUTUZUMAB | 100429026 |
| 10369572 | 10056602 | 1.75 | 51.2 | 03 | 2020-04-18 | 2020-04-18 | Azacitidine | 02 | N | AZACITIDINE | 100323856 |
| 10369662 | 10056606 | 1.64 | null | Palliative (P) | 2020-06-12 | 2020-10-14 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100142520 |
| 10369772 | 10056607 | 1.58 | 68.8 | Palliative (P) | 2018-12-29 | 2019-09-16 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101169015 |
| 10369910 | 10056608 | 0 | 68.8 | null | 2017-01-23 | 2017-01-28 | Carboplatin + Vinorelbine Oral | 02 | null | CARBOPLATIN + VINORELBINE | 101524358 |
| 10370151 | 10056610 | 1.77 | 70.3 | Palliative (P) | 2018-07-26 | 2018-08-02 | Capecitabine (21 day) + Irinotecan | 02 | N | NIRAPARIB | 100082446 |
| 10370417 | 10056611 | 1.8 | 68.3 | null | 2019-12-22 | 2019-12-26 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 100486495 |
| 10370515 | 10056612 | 1.68 | 74 | null | 2017-03-28 | 2019-04-18 | Trifluridine + Tipiracil | 02 | null | TIPIRACIL + TRIFLURIDINE | 101859752 |
| 10370593 | 10056613 | 1.52 | null | null | 2016-07-05 | 2016-08-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CISPLATIN + GEMCITABINE | 101250125 |
| 10370611 | 10056614 | 1.67 | 68 | Palliative (P) | 2021-03-11 | 2021-03-18 | Cabazitaxel | 02 | null | CABAZITAXEL | 100966611 |
| 10370656 | 10056615 | 1.7 | 98.25 | Palliative (P) | 2020-10-24 | 2021-02-06 | CABOZANTINIB | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101836863 |
| 10370826 | 10056617 | 1.7 | 78.1 | 03 | 2020-09-27 | 2020-12-19 | Gemcitabine weekly | 02 | N | GEMCITABINE | 100415103 |
| 10370832 | 10056618 | 1.7 | 100.55 | 03 | 2019-07-05 | 2019-07-05 | Cyclophosphamide oral | 02 | N | CYCLOPHOSPHAMIDE | 101709998 |
| 10370954 | 10056620 | 1.52 | 71 | Palliative (P) | 2019-09-19 | 2019-09-20 | Bortezomib +/- Dexamethasone | null | N | BORTEZOMIB | 100383388 |
| 10371080 | 10056621 | 1.61 | 93.2 | Adjuvant (A) | 2018-08-06 | 2018-09-06 | FLUOROURACIL | null | N | PERTUZUMAB + TRASTUZUMAB | 100708211 |
| 10371112 | 10056622 | 1.73 | 73.1 | 03 | 2018-08-01 | 2018-08-01 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101010777 |
| 10371291 | 10056623 | 1.8 | 75.9 | Palliative (P) | 2017-03-14 | 2017-03-16 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101470352 |
| 10371439 | 10056624 | 1.72 | 101 | 03 | 2017-01-17 | 2017-01-17 | CABOZANTINIB | 02 | N | CHLORAMBUCIL | 101008101 |
| 10371467 | 10056625 | 1.61 | 81.4 | Adjuvant (A) | 2019-09-14 | 2019-09-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | NIRAPARIB | 101067732 |
| 10371607 | 10056628 | 1.66 | 59.8 | null | 2019-06-17 | 2019-06-26 | Acalabrutinib | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100704184 |
| 10371665 | 10056629 | 1.52 | null | 03 | 2018-10-10 | 2019-01-31 | Bortezomib + Panobinostat | null | N | BORTEZOMIB + PANOBINOSTAT | 100496834 |
| 10371778 | 10056631 | 1.7 | 88.8 | null | 2019-04-13 | 2019-04-30 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | GEMCITABINE | 101048171 |
| 10371951 | 10056633 | 1.82 | 85.95 | Palliative (P) | 2019-06-11 | 2020-02-23 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100237364 |
| 10372076 | 10056634 | 1.57 | null | Palliative (P) | 2019-07-26 | 2019-09-18 | Acalabrutinib | 2 | N | DABRAFENIB | 101552053 |
| 10372214 | 10056635 | 0 | 81 | null | 2019-09-20 | 2019-09-20 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101566347 |
| 10372296 | 10056636 | 1.68 | 59 | null | 2017-04-17 | 2017-09-15 | Cabazitaxel | 02 | null | CABAZITAXEL | 101588932 |
| 10372411 | 10056638 | 1.71 | 83.5 | Palliative (P) | 2019-04-15 | 2019-04-15 | Vinorelbine (oral) | 02 | N | BORTEZOMIB + THALIDOMIDE | 101724871 |
| 10372468 | 10056639 | 1.72 | 88.2 | null | 2019-01-23 | 2019-02-09 | Chlorambucil | 02 | null | CHLORAMBUCIL | 100511834 |
| 10372545 | 10056641 | 1.73 | 66.5 | null | 2016-09-24 | 2019-02-19 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 101674853 |
| 10372614 | 10056643 | 1.76 | 65 | Palliative (P) | 2016-07-12 | 2016-07-27 | Vinorelbine (oral) | 02 | N | DABRAFENIB | 100242286 |
| 10372696 | 10056645 | 1.56 | 66.5 | null | 2012-07-26 | 2019-01-12 | Acalabrutinib | 02 | null | BUSULFAN | 100609012 |
| 10372860 | 10056646 | 1.58 | 70.6 | null | 2019-10-24 | 2019-11-11 | Azacitidine | 02 | null | AZACITIDINE | 101147460 |
| 10373030 | 10056647 | 1.75 | 71 | null | 2016-05-12 | 2016-05-12 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100237378 |
| 10373066 | 10056648 | 1.51 | 50 | null | 2020-02-25 | 2020-03-10 | Niraparib | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100977109 |
| 10373084 | 10056649 | 1.6 | 73.6 | null | 2018-02-08 | 2018-03-08 | CYCLO + RITUXIMAB + VINCRISTINE | null | null | ACALABRUTINIB | 100931040 |
| 10373186 | 10056650 | 1.8 | 86.2 | Palliative (P) | 2019-09-06 | 2019-11-22 | Cisplatin + Vinorelbine (IV) | 02 | N | DABRAFENIB | 101270990 |
| 10373347 | 10056652 | 1.7 | 74.3 | null | 2020-10-30 | 2020-10-31 | Cabazitaxel | 02 | null | CABAZITAXEL | 101222893 |
| 10373503 | 10056653 | null | 65.5 | Palliative (P) | 2017-07-27 | 2019-08-18 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100235713 |
| 10373551 | 10056654 | 1.77 | 89.9 | Curative (C) | 2018-10-09 | 2018-12-19 | FLUOROURACIL | 02 | null | CETUXIMAB | 100660407 |
| 10373856 | 10056655 | 1.54 | 68.6 | null | 2019-02-11 | 2019-03-25 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 100381016 |
| 10373859 | 10056656 | 1.61 | null | null | 2022-02-24 | 2022-03-08 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | GEMCITABINE | 101273141 |
| 10373878 | 10056657 | 1.66 | 55.45 | null | 2021-06-12 | 2021-06-16 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101081579 |
| 10373928 | 10056659 | null | 57.4 | null | null | 2021-12-08 | Melphalan oral | 02 | null | MELPHALAN | 100786051 |
| 10373964 | 10056660 | 1.75 | 89.3 | Palliative (P) | 2022-05-15 | 2022-05-19 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101467626 |
| 10374058 | 10056661 | 1.66 | 69.1 | null | 2019-06-24 | 2019-06-24 | Azacitidine | 02 | N | AZACITIDINE | 101097009 |